BG108167A - Използване на фармацевтичен състав за инхибиране растежа на туморни клетки при бозайници - Google Patents

Използване на фармацевтичен състав за инхибиране растежа на туморни клетки при бозайници

Info

Publication number: BG108167A
Authority: BG; Bulgaria
Prior art keywords: mammals; pharmaceutical composition; tumor cells; growth inhibition; taxanes
Prior art date: 2001-02-28

Application number

BG108167A

Other languages

English (en)

Inventor

Joseph Fargnoli

William C. Rose

Pamela Trail

Original Assignee

Bristol-Myers Squibb Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-28

Filing date

2003-09-09

Publication date

2004-09-30

2003-09-09 Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company

2004-09-30 Publication of BG108167A publication Critical patent/BG108167A/bg

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Carpets (AREA)
Epoxy Compounds (AREA)

BG108167A 2001-02-28 2003-09-09 Използване на фармацевтичен състав за инхибиране растежа на туморни клетки при бозайници BG108167A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27194401P	2001-02-28	2001-02-28
PCT/US2002/005971 WO2002067928A2 (en)	2001-02-28	2002-02-26	Metronomic dosing of taxanes for inhibiting tumor growth

Publications (1)

Publication Number	Publication Date
BG108167A true BG108167A (bg)	2004-09-30

Family

ID=23037749

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG108167A BG108167A (bg)	2001-02-28	2003-09-09	Използване на фармацевтичен състав за инхибиране растежа на туморни клетки при бозайници

Country Status (31)

Country	Link
EP (1)	EP1372636B1 (bg)
JP (1)	JP2004538253A (bg)
KR (1)	KR20030086276A (bg)
CN (1)	CN1533273A (bg)
AR (1)	AR033609A1 (bg)
AT (1)	ATE331511T1 (bg)
BG (1)	BG108167A (bg)
BR (1)	BR0207519A (bg)
CA (1)	CA2439299A1 (bg)
CY (1)	CY1105468T1 (bg)
CZ (1)	CZ20032232A3 (bg)
DE (2)	DE60212813T2 (bg)
DK (1)	DK1372636T3 (bg)
EE (1)	EE200300413A (bg)
ES (1)	ES2211374T3 (bg)
HR (1)	HRP20030775A2 (bg)
HU (1)	HUP0402115A2 (bg)
IL (1)	IL157356A0 (bg)
IS (1)	IS6924A (bg)
MX (1)	MXPA03007655A (bg)
NO (1)	NO20033809L (bg)
PE (1)	PE20020955A1 (bg)
PL (1)	PL373376A1 (bg)
PT (1)	PT1372636E (bg)
RU (1)	RU2003129233A (bg)
SK (1)	SK10332003A3 (bg)
TR (1)	TR200400375T3 (bg)
UY (1)	UY27185A1 (bg)
WO (1)	WO2002067928A2 (bg)
YU (1)	YU66603A (bg)
ZA (1)	ZA200306450B (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6750246B1 (en)	2000-02-03	2004-06-15	Bristol-Myers Squibb Company	C-4 carbonate taxanes
EP1673069B1 (en) *	2003-10-15	2016-10-12	SynCore Biotechnology CO., LTD	Cationic liposomes comprising an active drug for use in treatment of cancer
US9233094B2 (en)	2005-05-04	2016-01-12	Medigene Ag	Method of administering a cationic liposomal preparation
US8168216B2 (en)	2006-03-22	2012-05-01	Medigene Ag	Treatment of triple receptor negative breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0003546A3 (en) *	1997-05-27	2002-12-28	Baker Norton Pharma	Compositions for administering taxanes orally to human patients
US6750246B1 (en) *	2000-02-03	2004-06-15	Bristol-Myers Squibb Company	C-4 carbonate taxanes
US6362217B2 (en) *	2000-03-17	2002-03-26	Bristol-Myers Squibb Company	Taxane anticancer agents

2002
- 2002-02-25 UY UY27185A patent/UY27185A1/es not_active Application Discontinuation
- 2002-02-26 TR TR200400375T patent/TR200400375T3/xx unknown
- 2002-02-26 JP JP2002567295A patent/JP2004538253A/ja not_active Withdrawn
- 2002-02-26 RU RU2003129233/14A patent/RU2003129233A/ru not_active Application Discontinuation
- 2002-02-26 HR HR20030775A patent/HRP20030775A2/hr not_active Application Discontinuation
- 2002-02-26 BR BR0207519-9A patent/BR0207519A/pt not_active IP Right Cessation
- 2002-02-26 EE EEP200300413A patent/EE200300413A/xx unknown
- 2002-02-26 IL IL15735602A patent/IL157356A0/xx unknown
- 2002-02-26 CZ CZ20032232A patent/CZ20032232A3/cs unknown
- 2002-02-26 CN CNA028090306A patent/CN1533273A/zh active Pending
- 2002-02-26 DK DK02723255T patent/DK1372636T3/da active
- 2002-02-26 YU YU66603A patent/YU66603A/sh unknown
- 2002-02-26 SK SK1033-2003A patent/SK10332003A3/sk not_active Application Discontinuation
- 2002-02-26 PL PL02373376A patent/PL373376A1/xx not_active Application Discontinuation
- 2002-02-26 PT PT02723255T patent/PT1372636E/pt unknown
- 2002-02-26 AT AT02723255T patent/ATE331511T1/de not_active IP Right Cessation
- 2002-02-26 EP EP02723255A patent/EP1372636B1/en not_active Expired - Lifetime
- 2002-02-26 ES ES02723255T patent/ES2211374T3/es not_active Expired - Lifetime
- 2002-02-26 DE DE60212813T patent/DE60212813T2/de not_active Expired - Fee Related
- 2002-02-26 HU HU0402115A patent/HUP0402115A2/hu unknown
- 2002-02-26 MX MXPA03007655A patent/MXPA03007655A/es unknown
- 2002-02-26 CA CA002439299A patent/CA2439299A1/en not_active Abandoned
- 2002-02-26 DE DE0001372636T patent/DE02723255T1/de active Pending
- 2002-02-26 WO PCT/US2002/005971 patent/WO2002067928A2/en not_active Ceased
- 2002-02-26 KR KR10-2003-7011251A patent/KR20030086276A/ko not_active Withdrawn
- 2002-02-27 AR ARP020100688A patent/AR033609A1/es unknown
- 2002-02-27 PE PE2002000165A patent/PE20020955A1/es not_active Application Discontinuation
2003
- 2003-08-19 ZA ZA200306450A patent/ZA200306450B/xx unknown
- 2003-08-22 IS IS6924A patent/IS6924A/is unknown
- 2003-08-27 NO NO20033809A patent/NO20033809L/no unknown
- 2003-09-09 BG BG108167A patent/BG108167A/bg unknown
2006
- 2006-09-21 CY CY20061101360T patent/CY1105468T1/el unknown

Also Published As

Publication number	Publication date
SK10332003A3 (sk)	2005-03-04
HUP0402115A2 (hu)	2005-02-28
IL157356A0 (en)	2004-02-19
DK1372636T3 (da)	2006-11-06
ES2211374T1 (es)	2004-07-16
HRP20030775A2 (en)	2005-02-28
AR033609A1 (es)	2003-12-26
DE60212813T2 (de)	2007-01-18
NO20033809D0 (no)	2003-08-27
EP1372636A2 (en)	2004-01-02
KR20030086276A (ko)	2003-11-07
RU2003129233A (ru)	2005-02-10
MXPA03007655A (es)	2003-12-04
CN1533273A (zh)	2004-09-29
UY27185A1 (es)	2002-09-30
CZ20032232A3 (en)	2004-06-16
PL373376A1 (en)	2005-08-22
BR0207519A (pt)	2005-03-08
NO20033809L (no)	2003-10-23
ZA200306450B (en)	2004-11-19
IS6924A (is)	2003-08-22
DE60212813D1 (de)	2006-08-10
DE02723255T1 (de)	2004-07-15
PE20020955A1 (es)	2002-10-30
EE200300413A (et)	2003-12-15
WO2002067928A3 (en)	2003-10-09
WO2002067928A2 (en)	2002-09-06
EP1372636B1 (en)	2006-06-28
CA2439299A1 (en)	2002-09-06
TR200400375T3 (tr)	2004-04-21
PT1372636E (pt)	2006-09-29
CY1105468T1 (el)	2010-04-28
ATE331511T1 (de)	2006-07-15
YU66603A (sh)	2006-08-17
ES2211374T3 (es)	2007-03-01
JP2004538253A (ja)	2004-12-24

Similar Documents

Publication	Publication Date	Title
HUP0200391A2 (en)	2002-06-29	Use of pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth
GEP20053659B (en)	2005-11-10	Aryl And Heteroaryl Urea CHK1 Inhibitors for Use as Radiosensitizers and Chamosensitizers
BG106585A (bg)	2003-03-31	Киназни инхибитори като лекарствени средства
GEP20074213B (en)	2007-10-10	Novel inhibitors of kinases
BG106075A (bg)	2002-06-28	Използване на cyp2d6 инхибитори при комбинирано лечение
UA84460C2 (ru)	2008-10-27	Применение сульфонилкарбамидов для борьбы с нежелательным ростом растений в культурах бобовых
MXPA02005844A (es)	2004-08-12	Inhibidores de cinasas de proteina.
MY130727A (en)	2007-07-31	Controlled-release pharmaceutical formulations
MY140561A (en)	2009-12-31	Dosage form containing pde 4 inhibitor as active ingredient
IL144144A0 (en)	2002-05-23	Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
GEP20063831B (en)	2006-05-25	Substituted bicyclic derivatives for treatment of abnormal cell growth
MXPA04003674A (es)	2004-07-23	Uso mejorado de compuesto antitumoral en terapia de cancer.
GB0004128D0 (en)	2000-04-12	Novel compounds
UA74372C2 (uk)	2005-12-15	Інгібітори серинових протеаз, фармацевтична композиція на їх основі
SI1255537T1 (sl)	2006-10-31	Inhibitorji farnezil protein transferaze za zdravljenje raka dojk
MXPA03007857A (es)	2004-05-24	Compuestos y composiciones para entregar agentes activos.
GEP20104878B (en)	2010-01-11	Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
MXPA05012675A (es)	2006-02-22	Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa.
MXPA04006266A (es)	2004-09-27	Pirimidotriazinas como inhibidores de fosfatasa.
WO2001064199A3 (en)	2001-12-27	Farnesyl protein transferase inhibitor combinations with taxane compounds
AU2003296432A8 (en)	2004-07-29	Methods and compositions for inhibiting the growth of hematopoietic malignant cells
TW200510384A (en)	2005-03-16	Novel farnesyl protein transferase inhibitors as antitumor agents
GB9907571D0 (en)	1999-05-26	Compounds
MXPA04005809A (es)	2004-09-13	Inhibidores de proteinas quinasas.
BG108167A (bg)	2004-09-30	Използване на фармацевтичен състав за инхибиране растежа на туморни клетки при бозайници